Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Manfred Astl"'
Autor:
Lisa Seekircher, Annelies Mühlbacher, Lena Tschiderer, Gregor A. Wachter, Manfred Astl, Harald Schennach, Anita Siller, Peter Willeit
Publikováno v:
Vaccines, Vol 12, Iss 10, p 1156 (2024)
Background/Objectives: Antibodies against the hepatitis B surface antigen (anti-HBs) are a marker of immunity against hepatitis B virus (HBV) infections. There is uncertainty about the anti-HBs seroprevalence in the general population of Austria. Met
Externí odkaz:
https://doaj.org/article/1acd03d6a93d4e54bb71ba45d3e7c72e
Autor:
Anita Siller, Lisa Seekircher, Manfred Astl, Lena Tschiderer, Gregor A. Wachter, Julia Penz, Bernhard Pfeifer, Andreas Huber, Manfred Gaber, Harald Schennach, Peter Willeit
Publikováno v:
Vaccines, Vol 12, Iss 3, p 284 (2024)
Background: To provide updated estimates on SARS-CoV-2 antibody seroprevalence and average antibody titres for Central Europe. Methods: In repeat cross-sectional investigations (1 May 2022 to 9 March 2023) involving 28,768 blood donors in the Federal
Externí odkaz:
https://doaj.org/article/baa9c415a1b343d496b5e15fd715f2b6
Autor:
Lisa Seekircher, Anita Siller, Manfred Astl, Lena Tschiderer, Gregor A. Wachter, Bernhard Pfeifer, Andreas Huber, Manfred Gaber, Harald Schennach, Peter Willeit
Publikováno v:
Viruses, Vol 14, Iss 9, p 1877 (2022)
Because a large proportion of the Austrian population has been infected with SARS-CoV-2 during high incidence periods in winter 2021/2022, up-to-date estimates of seroprevalence of anti-SARS-CoV-2 antibodies are required to inform upcoming public hea
Externí odkaz:
https://doaj.org/article/8bf598bd27af423d8919b96f0a42aad6
Autor:
Anita Siller, Lisa Seekircher, Gregor A. Wachter, Manfred Astl, Lena Tschiderer, Bernhard Pfeifer, Manfred Gaber, Harald Schennach, Peter Willeit
Publikováno v:
Viruses, Vol 14, Iss 3, p 568 (2022)
There is uncertainty about the seroprevalence of anti-SARS-CoV-2 antibodies in the general population of Austria and about the waning of antibodies over time. We conducted a seroepidemiological study between June 2020 and September 2021, enrolling bl
Externí odkaz:
https://doaj.org/article/b38fcc1a042c454880223caba14005d0
Autor:
Franziska Spöck, Wegene Borena, Gregor A Wachter, Sabrina Neururer, Anja Vales, Manfred Astl, Sebastian Elmer, Harald Schennach, Manfred Gaber, Janine Kimpel, Anita Siller, Annelies Mühlbacher, Bernhard Pfeifer, Peter Willeit
Publikováno v:
Wiener Klinische Wochenschrift
Summary Background Seroepidemiological studies provide important insight into the spread of severe acute respiratory syndrome coronavirus 2 (SARS-CoV‑2) in our society. We aimed to determine seropositivity of SARS-CoV‑2 antibodies and its cross-s
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d623173d53ee8df1d7e5f97b3a5a8120
https://doi.org/10.1007/s00508-021-01963-3
https://doi.org/10.1007/s00508-021-01963-3
Autor:
Manfred Astl, Richard J. Benjamin, Chih Yu Chen, Jessica L. Hanover, Harald Schennach, Marco Amato, W. Nussbaumer, Jin-Sying Lin
Publikováno v:
Biology of Blood and Marrow Transplantation. 23:S190
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ed0eab65930d328d4193f75596303af6
https://doi.org/10.1016/j.bbmt.2016.12.369
https://doi.org/10.1016/j.bbmt.2016.12.369
Autor:
Manfred Astl, Harald Schennach, Richard J. Benjamin, Jin-Sying Lin, Marco Amato, Chih Yu Chen, Walter Nussbaumer
Publikováno v:
Blood. 128:2632-2632
The amotosalen/UVA process (INTERCEPT Blood System Cerus corp., CA) (IBS), is designed for the ex vivo preparation of pathogen-inactivated whole blood-derived and apheresis platelets. The system is intended to reduce the risk of transfusion-associate
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b77a988a0a23634b7c043231c6822969
https://doi.org/10.1182/blood.v128.22.2632.2632
https://doi.org/10.1182/blood.v128.22.2632.2632